# Neurosoft Bioelectronics

> Neurosoft Bioelectronics is a Geneva-based neurotechnology company, spun out of EPFL in 2019, building soft, stretchable brain-computer interfaces that sit on the surface of the cortex instead of piercing it. Its electrode arrays are engineered to be up to 100,000 times softer than the metal-and-plastic grids surgeons use today, cover far more of the brain, and slip in through a small opening rather than a large craniotomy. The company is running human clinical studies for drug-resistant epilepsy and severe tinnitus, and raised a $7.5M oversubscribed round in 2026 that brought total funding past $20 million.

- **Founded:** 2019
- **Headquarters:** Geneva, Switzerland
- **Founders:** Nicolas Vachicouras (CEO & Co-Founder), Ludovic Serex (COO & Co-Founder), Florian Fallegger (CTO & Co-Founder)
- **Team size:** ~23 employees
- **Products:** SOFT ECoG, MINDZ (Minimally Invasive Neuro Device), SOFT TINNIT, Synapsuit
- **Notable:** Recorded human brain activity with a first-in-human soft, stretchable electrode., Set a record for channel count in a soft brain interface: a 64-channel array on human cortex, double the 32-channel Houston study., Reported a 28-point average reduction on the Tinnitus Handicap Index in a proof-of-concept study - about 4x the clinically significant threshold.

## Products & services

- **SOFT ECoG** — Soft, high-density subdural electrode array for recording and stimulating the brain surface, used intra-operatively or implanted up to 30 days. Built with semiconductor-grade manufacturing for smaller electrodes, tighter pitch and MRI compatibility. Primary use: mapping drug-resistant epilepsy and monitoring during brain-tumor resection.
- **MINDZ (Minimally Invasive Neuro Device)** — A brain interface that folds and unfolds in extreme form factors so it can be deployed through a small burr hole rather than a full craniotomy, to localize epileptic foci with less surgical impact.
- **SOFT TINNIT** — A fully implantable closed-loop neuromodulation system that targets and modulates specific brain regions to suppress or reduce severe tinnitus.
- **Synapsuit** — A brain-computer interface pairing AI decoding with a lightweight soft wearable exosuit to restore real-time upper-limb movement, developed with the Wyss Center, Korea Electronics Technology Institute and Jang EUN FnC.

## Achievements

- Recorded human brain activity with a first-in-human soft, stretchable electrode.
- Set a record for channel count in a soft brain interface: a 64-channel array on human cortex, double the 32-channel Houston study.
- Reported a 28-point average reduction on the Tinnitus Handicap Index in a proof-of-concept study - about 4x the clinically significant threshold.
- Built a portfolio of 25+ patents and 25+ peer-reviewed publications.
- Raised a $7.5M oversubscribed round in 2026, bringing total funding past $20 million.
- Won CHF 150,000 from Venture Kick and secured SERI support to advance implantable electrodes.

## Latest updates

- **2026-05** — Closed a $7.5M oversubscribed seed round led by Skybound Venture Capital, bringing total funding past $20 million.
- **2026-05** — Reported a record-setting 64-channel soft brain interface tested in human epilepsy patients at UMC Utrecht, with a 12-patient validation study planned.
- **2025** — Expanded the product line to MINDZ, SOFT TINNIT and the Synapsuit BCI-exosuit collaboration.

## Links

- Website: https://neurosoft-bio.com
- LinkedIn: http://www.linkedin.com/company/neurosoft-bioelectronics
- Twitter/X: https://twitter.com/NeurosoftBio

---

Profile page: https://yespress.io/neurosoft-bioelectronics
Published by YesPress — https://yespress.io
Last updated: 2026-08-19